Biomedical Engineering Reference
In-Depth Information
[25] S. Y. Shaw. Molecular imaging in cardiovascular disease: targets and
opportunities. Nature Reviews Cardiology, 6(9):569{579, 2009.
[26] M. Stelljes, S. Hermann, J. Albring, G. Kohler, M. Loer, C. Franz-
ius, C. Poremba, V. Schlosser, S. Volkmann, C. Opitz, C. Bremer,
T. Kucharzik, G. Silling, O. Schober, W. E. Berdel, M. Schafers, and
J. Kienast. Clinical molecular imaging in intestinal graft-versus-host dis-
ease: mapping of disease activity, prediction, and monitoring of treatment
eciency by positron emission tomography.
Blood, 111(5):2909{2918,
2008.
[27] W. Wadsak and M. Mitterhauser. Basics and principles of radiopharma-
ceuticals for PET/CT.
European Journal of Radiology, 73(3):461{469,
2010.
[28] Y. Waerzeggers, M. Klein, H. Miletic, U. Himmelreich, H. Li, P. Mon-
fared, U. Herrlinger, M. Hoehn, H. H. Coenen, M. Weller, A. Winkeler,
and A. H. Jacobs. Multimodal imaging of neural progenitor cell fate in
rodents. Molecular Imaging, 7(2):77{91, 2008.
[29] R.
Weissleder
and
U.
Mahmood.
Molecular
imaging.
Radiology,
219(2):316{333, 2001.
[30] R. Weissleder and M. J. Pittet. Imaging in the era of molecular oncology.
Nature, 452(7187):580{589, 2008.
[31] J. K. Willmann, N. van Bruggen, L. M. Dinkelborg, and S. S. Gambhir.
Molecular imaging in drug development. Nature Reviews Drug Discovery,
7(7):591{607, 2008.
Search WWH ::
Custom Search